Y10S 530/86
Renin inhibitors
Y10S530/86 (Renin inhibitors) appears on 144 US grants and 5 published applications in this corpus.
Search patents in Y10S- Granted patents
- 144
- Published applications
- 5
- Assignees
- 40
- Inventors
- 177
- Latest grant
- 22 Dec 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 10 | 0 |
| 1985 | 4 | 0 |
| 1986 | 8 | 0 |
| 1987 | 23 | 0 |
| 1988 | 22 | 0 |
| 1989 | 34 | 0 |
| 1990 | 23 | 0 |
| 1991 | 5 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent22 Dec 2020US 10,870,693 B2OncoMed Pharmaceuticals, Inc.
- Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent29 May 2018US 9,982,042 B2OncoMed Pharmaceuticals, Inc.
- Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent6 Dec 2016US 9,511,139 B2OncoMed Pharmaceuticals, Inc.
- Methods of treatment with DLL4 antagonists and an anti-hypertensive agent11 Nov 2014US 8,883,145 B2OncoMed Pharmaceuticals, Inc.
- Drug screening and diagnosis based on paracrine tubular renin-angiotensin system6 Jul 2010US 7,749,725 B2University of Utah Research Foundation
- Therapeutic combination and methods of treatment wtih a dll4 antagonist and an anti-hypertensive agent6 Dec 2018US 2018/0346556 A1OncoMed Pharmaceuticals, Inc.
- Therapeutic Combination and Methods of Treatment With A DLL4 Antagonist and an Anti-Hypertensive Agent15 Jun 2017US 2017/0166632 A1OncoMed Pharmaceuticals, Inc.
- Therapeutic Combination and Methods of Treatment With A DLL4 Antagonist and an Anti-Hypertensive Agent30 Apr 2015US 2015/0118232 A1OncoMed Pharmaceuticals, Inc.
- Therapeutic Combination and Methods of Treatment With a DLL4 Antagonist and an Anti-Hypertensive Agent18 Oct 2012US 2012/0263721 A1OncoMed Pharmaceuticals, Inc.
- Drug screening and diagnosis based on paracrine tubular renin-angiotensin system20 Feb 2003US 2003/0036208 A1University of Utah Research Foundation, a Utah corporation
Most cited
By later US patents
- Hypotensive peptides and their use161US 4,548,926 ASankyo Company, Limited · 1985
- Intermediates in polypeptide synthesis157US 4,599,198 APfizer Inc. · 1986
- Renin inhibitory tripeptides154US 4,668,770 AMerck & Co., Inc. · 1987
- Amino acid ester and amide renin inhibitor152US 4,616,088 AE. R. Squibb & Sons, Inc. · 1986
- Renin inhibitors containing a C-terminal disulfide cycle147US 4,477,441 AMerck & Co., Inc. · 1984